Acral Sclerosis due to Interferon-Alpha-2b in Chronic Myelogenous Leukemia

Publisher： Karger

E-ISSN： 1421-9662|107|1|43-45

ISSN： 0001-5792

Source： Acta Haematologica, Vol.107, Iss.1, 2002-01, pp. : 43-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Sensitivity to Interferon-Alpha and Interferon-Stimulated Gene Factor 3 Binding Activity in Human Chronic Myelogenous Leukemia Cell Line KT-1

By  

Acta Haematologica, Vol. 104, Iss. 1, 2000-11 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Thrombotic Thrombocytopenic Purpura during Interferon Alpha Treatment for Chronic Myelogenous Leukemia

By  

Acta Haematologica, Vol. 102, Iss. 3, 2004-11 ,pp. : 160-162

Karger

Access to resources Recommend Favorite

Lamivudine and Famciclovir Combination Therapy with or without Addition of Interferon-alpha-2b for HBeAg-positive Chronic Hepatitis B: A Pilot Study

By Sangfelt Per   Uhnoo Ingrid   Hollander Anna   Lindh Gudrun   Weiland Ola  

Scandinavian Journal of Infectious Diseases, Vol. 34, Iss. 7, 2002-07 ,pp. : 505-511

Informa Healthcare

Access to resources Recommend Favorite

Interferon‐alpha 2b (IFNα) for Early‐Phase Chronic Lymphocytic Leukaemia with High Risk for Disease Progression: Results of a Randomized Multicentre Study

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 1996-08 ,pp. : 362-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon‐alpha 2b (IFNα) for Early‐Phase Chronic Lymphocytic Leukaemia with High Risk for Disease Progression: Results of a Randomized Multicentre Study

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 1996-08 ,pp. : 362-369

John Wiley & Sons Inc

Access to resources Recommend Favorite